Research Article
Clinical Predictors of Pseudomonas aeruginosa Bacteremia in Emergency Department
Table 2
Additional characteristics of patients with Pseudomonas bacteremia in the ED including antimicrobial susceptibility profile of the isolates.
| | Characteristics | Case (n = 54) |
| | Infection type |
| | Community-acquired | 76% | | Healthcare-associated | 7% | | Hospital-acquired | 17% |
| | Antimicrobial susceptibility | | | Aztreonam | 50% | | Ceftazidime | 85% | | Cefepime | 83% | | Piperacillin-Tazobactam | 81% | | Ciprofloxacin | 80% | | Amikacin | 96% | | Imipenem | 83% | | Meropenem | 83% | Colistin
| 100% |
| | Multidrug-resistance | 22% | | Use of inappropriate antibiotics | 44% | 1-year mortality, no (%)
| 33 (61) |
|
|
